eF-site ID 1h2u-X
PDB Code 1h2u
Chain X

click to enlarge
Title Structure of the human nuclear cap-binding-complex (CBC) in complex with a cap analogue m7GpppG
Classification NUCLEAR PROTEIN
Compound 80 KDA NUCLEAR CAP BINDING PROTEIN
Source (CB20_HUMAN)
Sequence X:  GLLKALRSDSYVELSQYRDQHFRGDNEEQEKLLKKSCTLY
VGNLSFYTTEEQIYELFSKSGDIKKIIMGLDKMKKTACGF
CFVEYYSRADAENAMRYINGTRLDDRIIRTDWDAGFKEGR
QYGRGRSGGQVRDEYRQDYDAGRGGYGKL
Description


Functional site

1) chain X
residue 20
type
sequence Y
description BINDING SITE FOR RESIDUE GDP X1153
source : AC1

2) chain X
residue 127
type
sequence R
description BINDING SITE FOR RESIDUE GDP X1153
source : AC1

3) chain X
residue 134
type
sequence V
description BINDING SITE FOR RESIDUE GDP X1153
source : AC1

4) chain X
residue 135
type
sequence R
description BINDING SITE FOR RESIDUE GDP X1153
source : AC1

5) chain X
residue 20
type
sequence Y
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

6) chain X
residue 22
type
sequence D
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

7) chain X
residue 43
type
sequence Y
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

8) chain X
residue 83
type
sequence F
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

9) chain X
residue 112
type
sequence R
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

10) chain X
residue 114
type
sequence D
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

11) chain X
residue 115
type
sequence W
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

12) chain X
residue 116
type
sequence D
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

13) chain X
residue 123
type
sequence R
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

14) chain X
residue 125
type
sequence Y
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

15) chain X
residue 126
type
sequence G
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

16) chain X
residue 127
type
sequence R
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

17) chain X
residue 133
type
sequence Q
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

18) chain X
residue 134
type
sequence V
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

19) chain X
residue 135
type
sequence R
description BINDING SITE FOR RESIDUE 7MG X1154
source : AC2

20) chain X
residue 23
type
sequence Q
description BINDING SITE FOR RESIDUE GDP Y1152
source : AC3

21) chain X
residue 25
type
sequence F
description BINDING SITE FOR RESIDUE GDP Y1152
source : AC3

22) chain X
residue 27
type
sequence G
description BINDING SITE FOR RESIDUE GDP Y1152
source : AC3

23) chain X
residue 20
type BINDING
sequence Y
description BINDING => ECO:0000269|PubMed:12374755, ECO:0000269|PubMed:12434151
source Swiss-Prot : SWS_FT_FI1

24) chain X
residue 43
type BINDING
sequence Y
description BINDING => ECO:0000269|PubMed:12374755, ECO:0000269|PubMed:12434151
source Swiss-Prot : SWS_FT_FI1

25) chain X
residue 112
type BINDING
sequence R
description
source Swiss-Prot : SWS_FT_FI2

26) chain X
residue 123
type BINDING
sequence R
description
source Swiss-Prot : SWS_FT_FI2

27) chain X
residue 133
type BINDING
sequence Q
description
source Swiss-Prot : SWS_FT_FI2

28) chain X
residue 13
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:23186163
source Swiss-Prot : SWS_FT_FI4

29) chain X
residue 18
type MOD_RES
sequence S
description Phosphoserine => ECO:0007744|PubMed:17525332
source Swiss-Prot : SWS_FT_FI5

30) chain X
residue 146
type MOD_RES
sequence R
description Omega-N-methylarginine => ECO:0007744|PubMed:24129315
source Swiss-Prot : SWS_FT_FI6


Display surface

Download
Links